Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Long-Term Investments (2016)

Perspective Therapeutics' Long-Term Investments history spans 3 years, with the latest figure at $3.0 million for Q2 2016.

  • For Q2 2016, Long-Term Investments fell 41.78% year-over-year to $3.0 million; the TTM value through Jun 2016 reached $3.0 million, down 41.78%, while the annual FY2016 figure was $3.0 million, 41.78% down from the prior year.
  • Long-Term Investments for Q2 2016 was $3.0 million at Perspective Therapeutics, down from $5.2 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $5.4 million in Q2 2014 and bottomed at $3.0 million in Q2 2016.
  • The 3-year median for Long-Term Investments is $5.2 million (2015), against an average of $4.8 million.
  • The largest annual shift saw Long-Term Investments decreased 5.45% in 2015 before it crashed 41.78% in 2016.
  • A 3-year view of Long-Term Investments shows it stood at $5.4 million in 2014, then fell by 4.4% to $5.2 million in 2015, then plummeted by 42.42% to $3.0 million in 2016.
  • Per Business Quant, the three most recent readings for CATX's Long-Term Investments are $3.0 million (Q2 2016), $5.2 million (Q1 2016), and $5.2 million (Q4 2015).